Conference - Seattle, WА, United States
Today, biospecimen collections are used by multiple research groups for varying research aims, from basic research through clinical trials. A well-managed biobank is a critical prerequisite for high-quality biological research. The proper collection, processing, storage and tracking of biospecimens are critical components allowing researchers to better link molecular and clinical information. Thus, by necessity, biobanking is both a science and a business. Cambridge Healthtech Institute’s Sixth Annual Leaders in Biobanking Congress: Maximizing Your Investment in Biospecimens addresses both the business and science of biobanking, bringing together biomedical and biopharmaceutical researchers, regulators, biorepository managers and practitioners to investigate the best strategies for effective use of biospecimens within today's cutting-edge research.
Organization: Cambridge Healthtech Institute
(Courtesy of Leaders in Biobanking Congress 2014 logo, via www.healthtech.com)
For more information, please visit: www.healthtech.com/biobanking
September 15, 2014 - September 17, 2014
Sheraton Seattle Hotel
Seattle, Washington 98101, USA
Contact: Kris Waterman (email@example.com)
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.